Xingqi Pharmaceutical
30057342.480.85% ( +0.36 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Xingqi Pharmaceutical(300573) the Revenue is 683.34 M (+27.45%);the EBIT is 229.38 M (+23.68%);the EPS is 0.579 (+42.37%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.68B27.45%
----
----
EBIT
0.23B23.68%
----
----
EPS
0.579342.37%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf